Geriatric Pharmacotherapy Case Series: Thiazide-Induced Hypokalemia

Sr Care Pharm. 2022 Dec 1;37(12):605-611. doi: 10.4140/TCP.n.2022.605.

Abstract

Introduction The patient was a 72-year-old man with a history of hypertension, hyperlipidemia, benign prostatic hyperplasia, and oropharyngeal cancer. His home medications include amlodipine, atorvastatin, hydrochlorothiazide, and tamsulosin. He lives alone and eats a soft, bland, nutrient-poor diet. During his annual primary care visit, he is found to have a serum potassium level of 3.3 mEq/L (reference range 3.5-5.0). Assessment The use of hydrochlorothiazide, a thiazide diuretic, as well as his low consumption of dietary potassium, have likely contributed to his mild, asymptomatic hypokalemia. Outcome The patient's serum potassium normalizes following replenishment with a 10 mEq microencapsulated potassium chloride (KCl) extended release (ER) tablet three times a day with meals for one week. A registered dietitian was consulted to provide recommendations for a well-balanced diet, consistent with his dietary texture needs. Conclusions Hypokalemia is a commonly encountered electrolyte disorder, occurring in about 3 to 4% of community-dwelling elders.1 Though asymptomatic hypokalemia is often an incidental finding, it is associated with an increased risk of major adverse cardiovascular events if left untreated and thus should be promptly corrected when discovered.².

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Humans
  • Hydrochlorothiazide / adverse effects
  • Hypokalemia* / chemically induced
  • Male
  • Potassium / therapeutic use
  • Tamsulosin
  • Thiazides*

Substances

  • Thiazides
  • Hydrochlorothiazide
  • Tamsulosin
  • Potassium